A post-marketing survey evaluating the safety and efficacy of a fixed-dose single-pill combination of cilnidipine and valsartan in patients with hypertension: Real-world JSH 2014 and 2019 implementations

A post-marketing survey evaluating the safety and efficacy of a fixed-dose single-pill combination of cilnidipine and valsartan in patients with hypertension: Real-world JSH 2014 and 2019 implementations

Methods : The home blood pressure control by a single-pill combination of cilnidipine and valsartan (HOPE-Combi) survey sought to evaluate the safety and efficacy of cilnidipine 10 mg/valsartan 80 mg single-pill combination (SPC of Cil/Val) treatment in patients with hypertension for over 12 months....

Full description

Bibliographic Details
Main Authors: Saori Matsuda, Shinobu Nagahama, Yoshiki Kurose, Maki Wakabayashi, Hitoshi Sugii, Tsukasa Teshima, Noriyuki Suzuki, Kazuomi Kario
Format: Article
Language:English
Published: Taylor & Francis Group 2020-08-01
Series:Clinical and Experimental Hypertension
Subjects:
hope-combi survey
single-pill combination
post-marketing survey
cilnidipine
valsartan
jsh 2019
Online Access:http://dx.doi.org/10.1080/10641963.2020.1714641

Internet

http://dx.doi.org/10.1080/10641963.2020.1714641

Similar Items